Replies to post #3568 on Immune Pharmaceuticals Inc (fka IMNPQ)

[Letterpenny]

The shareholders will get nothing from Ceplene deal. It’s a straight asset sale. They are assuming all the debt and the liabilities. They’ve assumed the contingents as well. There will only be 2.5 million in cash given to IMNP. Now divide that 2.5 in half due to taxes and that’s what IMNP will get. Shareholders won’t see a penny from Ceplene deal. Hopefully we’ll do ok off second sale. But I see Armory securities is allowing assumption of assets as well. Oh man. Maybe Bert will be a bust too. Hard cash is always best. Assumption sucks. Empty promises